|
1.
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
2.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics. 2002 CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3.
|
Hermans J, Bonenkamp JJ, Boon MC, et al:
Adjuvant therapy after curative resection for gastric cancer:
meta-analysis of randomized trials. J Clin Oncol. 11:1441–1447.
1993.PubMed/NCBI
|
|
4.
|
Jackson CB and Giraud AS: STAT3 as a
prognostic marker in human gastric cancer. J Gastroenterol Hepatol.
24:505–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Arya M, Patel HR and Williamson M:
Chemokines: key players in cancer. Curr Med Res Opin. 19:557–564.
2003. View Article : Google Scholar
|
|
6.
|
Burger JA and Kipps TJ: CXCR4: a key
receptor in the crosstalk between tumor cells and their
microenvironment. Blood. 107:1761–1767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Scotton CJ, Wilson JL, Scott K, et al:
Multiple actions of the chemokine CXCL12 on epithelial tumor cells
in human ovarian cancer. Cancer Res. 62:5930–5938. 2002.PubMed/NCBI
|
|
8.
|
Barbieri F, Bajetto A, Stumm R, et al:
Overexpression of stromal cell-derived factor 1 and its receptor
CXCR4 induces autocrine/paracrine cell proliferation in human
pituitary adenomas. Clin Cancer Res. 14:5022–5032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Koshiba T, Hosotani R, Miyamoto Y, et al:
Expression of stromal cell-derived factor 1 and CXCR4 ligand
receptor system in pancreatic cancer: a possible role for tumor
progression. Clin Cancer Res. 6:3530–3535. 2000.PubMed/NCBI
|
|
10.
|
Muller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ganju RK, Brubaker SA, Meyer J, et al: The
alpha-chemokine, stromal cell-derived factor-1, binds to the
transmembrane G-protein-coupled CXCR-4 receptor and activates
multiple signal transduction pathways. J Biol Chem.
273:23169–23175. 1998. View Article : Google Scholar
|
|
12.
|
Oh JW, Drabik K, Kutsch O, Choi C, Tousson
A and Benveniste EN: CXC chemokine receptor 4 expression and
function in human astroglioma cells. J Immunol. 166:2695–2704.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Orimo A, Gupta PB, Sgroi DC, et al:
Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12
secretion. Cell. 121:335–348. 2005. View Article : Google Scholar
|
|
14.
|
Mirisola V, Zuccarino A, Bachmeier BE, et
al: CXCL12/SDF1 expression by breast cancers is an independent
prognostic marker of disease-free and overall survival. Eur J
Cancer. 45:2579–2587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yoshitake N, Fukui H, Yamagishi H, et al:
Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node
metastasis in colorectal cancer. Br J Cancer. 98:1682–1689. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Schimanski CC, Schwald S, Simiantonaki N,
et al: Effect of chemokine receptors CXCR4 and CCR7 on the
metastatic behavior of human colorectal cancer. Clin Cancer Res.
11:1743–1750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Arigami T, Natsugoe S, Uenosono Y, et al:
CCR7 and CXCR4 expression predicts lymph node status including
micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yasumoto K, Koizumi K, Kawashima A, et al:
Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of
gastric cancer. Cancer Res. 66:2181–2187. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hashimoto I, Koizumi K, Tatematsu M, et
al: Blocking on the CXCR4/mTOR signalling pathway induces the
anti-metastatic properties and autophagic cell death in peritoneal
disseminated gastric cancer cells. Eur J Cancer. 44:1022–1029.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Zieker D, Königsrainer I, Traub F, et al:
PGK1 a potential marker for peritoneal dissemination in gastric
cancer. Cell Physiol Biochem. 21:429–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Lee HJ, Kim SW, Kim HY, et al: Chemokine
receptor CXCR4 expression, function, and clinical implications in
gastric cancer. Int J Oncol. 34:473–480. 2009.PubMed/NCBI
|
|
22.
|
Ishigami S, Natsugoe S, Okumura H, et al:
Clinical implication of CXCL12 expression in gastric cancer. Ann
Surg Oncol. 14:3154–3158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Japanese Gastric Cancer Association:
Japanese Classification of Gastric Carcinoma. (2nd English
edition). Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar
|
|
24.
|
Kim SW, Kim HY, Lee HJ, Yun HJ, Kim S and
Jo DY: Stromal cell-derived factor-1 promotes myeloma cell growth
in both aurocrine and paracrine manners. Korean J Hematol.
43:127–137. 2008. View Article : Google Scholar
|
|
25.
|
Guleng B, Tateishi K, Ohta M, et al:
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates
in vivo tumor growth by inhibiting angiogenesis in a vascular
endothelial growth factor-independent manner. Cancer Res.
65:5864–5871. 2005. View Article : Google Scholar
|
|
26.
|
Schimanski CC, Galle PR and Moehler M:
Chemokine receptor CXCR4 – prognostic factor for gastrointestinal
tumors. World J Gastroenterol. 14:4721–4724. 2008.
|
|
27.
|
Iwasa S, Yanagawa T, Fan J and Katoh R:
Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric
cancer is associated with lymph node and liver metastasis.
Anticancer Res. 29:4751–4758. 2009.PubMed/NCBI
|
|
28.
|
Tsuboi K, Kodera Y, Nakanishi H, et al:
Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not
correlate with peritoneal metastasis. Oncol Rep. 20:1117–1123.
2008.PubMed/NCBI
|
